Skin disease Archives

In Depth 16 Jul 2025

Eight rare autoimmune diseases biotechs are fighting to treat

Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them.

July 16, 2025 - 12 minutesmins - By Willow Shah-Neville

In Depth 21 May 2025

Gene therapy for skin diseases: A field still finding its footing

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of something more?

May 21, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 4 Apr 2024

Regenerative medicine and tissue engineering: Six companies leading the way

Discover six innovative companies leading the way in the evolving landscape of the tissue engineering and regenerative medicine industry.

April 4, 2024 - 8 minutesmins - By Jules Adam

In Depth 8 Feb 2024

Could we see a new dawn for hair loss treatments?

Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.

February 8, 2024 - 8 minutesmins - By David Cox

Podcast 5 Jan 2024

Gene editing in the microbiome could provide acne solution

Explore Eligo Bioscience’s groundbreaking CRISPR-based approach, modifying the microbiome to combat moderate to severe acne.

January 5, 2024

Best in Biotech 23 Aug 2023

Latest advancements in psoriasis research over the past year

Psoriasis, an autoimmune condition that causes flaky patches of skin to form scales, occurs when the body’s immune system attacks its own healthy skin cells. And because people with psoriasis have an increased production of skin cells, these cells – which are normally renewed every three to four weeks – regenerate in under a week. […]

August 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 23 Jun 2023

Breakthrough treatment for skin infections?

A research team led by Kelvin Yeung from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has designed a new microneedle patch that provides an effective non-antibiotic approach for the treatment of skin infections. The design engineered with ultrasound-responsive zinc-based metal-organic framework (MOF) […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Mar 2023

Intracellular “smoke detector” discovery has skin disease therapy implications

A study by the University of Bonn in Germany could lead to therapies against skin and intestinal diseases in the medium term.Researchers at the universities of Bonn and Singapore have discovered a new intracellular “smoke detector.” The sensor warns of damage to the mitochondria – the microscopic power plants that supply the cell with energy. […]

March 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 27 Jan 2023

Dupixent gets EU nod for children with severe atopic dermatitis

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Dupixent (dupilumab), recommending expanded approval in the European Union (EU) to treat severe atopic dermatitis in children six months to five years old who are candidates for systemic therapy. The European Commission is expected to announce a final […]

January 27, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 4 Jan 2023

Aditxt forms Adimune to focus on immune modulation therapies

Aditxt, Inc., a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has formed a U.S.-based subsidiary Adimune, Inc. The plan is to submit a clinical trial application (CTA) for its immunotherapeutic technology drug candidate, ADI-100 (ADI). The CTA will request approval for Adimune to conduct the […]

January 4, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Dec 2022

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy. Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical trials […]

December 15, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 30 Nov 2022

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position in a portfolio of immunodermatology assets from Asana BioSciences. The Libertas Bio pipeline now includes global rights to gusacitinib, an oral phase 3-ready dual JAK/SYK inhibitor in development for chronic hand eczema (CHE), and ASN008, a phase 2-ready topical sodium […]

November 30, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Skin disease

Eight rare autoimmune diseases biotechs are fighting to treat

Gene therapy for skin diseases: A field still finding its footing

Regenerative medicine and tissue engineering: Six companies leading the way

Could we see a new dawn for hair loss treatments?

Gene editing in the microbiome could provide acne solution

Latest advancements in psoriasis research over the past year

Breakthrough treatment for skin infections?

Intracellular “smoke detector” discovery has skin disease therapy implications

Dupixent gets EU nod for children with severe atopic dermatitis

Aditxt forms Adimune to focus on immune modulation therapies

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!